Management of Dengue Shock Syndrome A Prospective Study

  • H. Tjandra Bhayangkara Police Hospital, Kediri, Central Java
Keywords: dengue, dengue shock syndrome, DHF, DSS

Abstract

Since dengue hemorrhagic fever (DHF) was first reported 20 years ago, the only serious variant of the disease, dengue shock syndrome (DSS), still continues to cause a relatively high mortality. An effective yet simple management of DSS which can be carried out in every hospital is certainly necessary if the dead toll is ro be reduced. Prospective study of a simple procedure in managing DSS patients in Bhayangkara Police Hospital Kediri is reported. Depends on the severity of the disease, for DHF grade III: 20 mL/kg bw Lactated - Ringer solution was given at free rare. This is followed by 20 mL/kg bw of synthetic plasma expander (expafusin) in a rate of thrice tire body weight and continued with lactated-ringer and 5% dextrose in I 12 Saline alternately with a rate of twice the body weight per minute for the remaining first 14 hours. For DHF grade IV, the same fluids were given, except for the amount and the infusion rate. Drugs administered and medical care were all the same/or both groups. A close observation, a critical assessment, and an accurate as well as a rapid action are very important factors. Totally there were 11 S patients of which 8 died. The mortality rate was 7%. A better management and/or treatment has to be developed 10 further reduce the mortality.

References

1. KHO LK, WULUR H, KARSONO A, THAIB S. Dengue haemorrhagic Fever in Jakarta. MKI 1969; 19: 417.
2. PARTANA L, PARTANA JS, THARlR S. Hemorrhagic Fever shock syndrome in Surabaya, Indonesia. Kobe, J Med Sci 1970; 16 : 189.
3. SUMARMO SPS. Demam berdarah dengue pada anak. Tesis. UI Press. 1988; FL
4. SUMARMO SPS. Tinjauan pustaka: Penatalaksanaan demam berdarah dengue, M.K.I. no. 2 thn. 15, 28 Pebruari 1989 : 161-70.
5. HENDARTO T. Terapi cairan pada shock. Medika no. 4 thn. 14, April 1988; 348-55.
6 ROWE M, ARANYO A. The choice of intravenous fluid in shock resusitation. Paediat Clins N Am 1975; 22: 269. ·
7. AZIZ AL. Syok pada demam berdarah dengue. Diajukan pada simposium shock. Surabaya, 10 Februari 1990. ·
8. LATIEF A, HASSAN R, SUMARMO SPS. Beberapa penyulit dalam pengobatan "Demam berdarah dengue syndrome berat". Demam berdarah dengue: Sepuluh tahun penelitian pada anak di Jakarta. Balai Penerbitan FKUI, Jakarta 1985; 219-25.
9. W H 0 Dengue haemorrhagic fever: Diagnosis, treatment and control. Geneva (1986).
10. SHAMBI WP, WELL HH, UNHOJI VN. Acute pharmacodynamic effect and related haemodynamic changes in normal subjects and patients in shock. Circvlation 1965; 31: 523. Cited from Sumarmo SPS. Demam Berdarah Dengue Pada Anak. Tesis. Ul Press 1988; 171.
11. SCHUMER W, SPERLING R. Shock and its effect on the cell. J AM Med Ass 1968; 205: 4. Cited from Sumarmo SPS. Demam berdarah dengue pada anak. Tesis Ul Press 1988; 171.
12. RAMPENGAN TH. Demam berdarah dengue pada anak di RSU Manado. M.K.I. 1986; 36: 300-5.
13. RAMPENGAN TH. Pemberian cairan pada DSS. M K I 1987; 37: 654-9.
14. MUNIR M, RAMPENGAN TH. DSS. An evaluation of clinical experiences. Paediatr Indones 1984; 24: 254-64.
15. ATMODJO D. Pengelolaan demam berdarah dengue berat. Simposium pengelolaan kegawatan pada anak .. Semarang, 5 April 1986; 54-64.
Published
1991-12-31
How to Cite
1.
Tjandra H. Management of Dengue Shock Syndrome A Prospective Study. PI [Internet]. 31Dec.1991 [cited 29Mar.2024];31(11-12):289-3. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/1449
Received 2017-05-30
Accepted 2017-05-30
Published 1991-12-31